OncoTherapy Science, Inc.
TSE:4564.T
32 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 610.118 | 1,134.903 | 1,153.663 | 332.477 | 316.215 | 280.586 | 211.251 | 286.667 | 266.903 | 769.956 | 1,017.769 | 3,277.411 | 6,223.947 | 5,361.397 | 5,257.628 | 3,327.575 | 1,972.835 | 804.491 | 1,164.764 | 1,580 |
| Cost of Revenue
| 787.836 | 1,093.218 | 1,039.751 | 312.935 | 366.331 | 2,827 | 2,932 | 2,938 | 125.933 | 2,394 | 4,472 | 4,123 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -177.718 | 41.685 | 113.912 | 19.542 | -50.116 | -2,546.414 | -2,720.749 | -2,651.333 | 140.97 | -1,624.044 | -3,454.231 | -845.589 | 6,223.947 | 5,361.397 | 5,257.628 | 3,327.575 | 1,972.835 | 804.491 | 1,164.764 | 1,580 |
| Gross Profit Ratio
| -0.291 | 0.037 | 0.099 | 0.059 | -0.158 | -9.075 | -12.879 | -9.249 | 0.528 | -2.109 | -3.394 | -0.258 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 678.051 | 716.463 | 1,730.27 | 1,375.683 | 1,742.168 | 2,826.639 | 2,931.901 | 2,938.15 | 2,883.74 | 2,393.635 | 4,472.078 | 4,122.828 | 4,715.369 | 4,753.005 | 4,577.489 | 3,009.59 | 2,049.253 | 1,872.554 | 1,769.182 | 1,135.286 |
| General & Administrative Expenses
| 265.03 | 431.637 | 436.279 | 281.795 | 397.379 | 407.723 | 267.945 | 352.739 | 364.062 | 338.795 | 331.552 | 268.335 | 324.441 | 385.068 | 361.465 | 290.816 | 309.007 | 280.619 | 229.03 | 409.592 |
| Selling & Marketing Expenses
| -4.35 | 0 | 0 | 0 | 0 | 44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 260.68 | 431.637 | 436.279 | 281.795 | 397.379 | 407.723 | 267.945 | 352.739 | 364.062 | 338.795 | 331.552 | 268.335 | 324.441 | 385.068 | 361.465 | 290.816 | 309.007 | 280.619 | 229.03 | 409.592 |
| Other Expenses
| -4.35 | -15.804 | 0.611 | 1.344 | 0.07 | -107.178 | -0.014 | 0.11 | 0.165 | 17.073 | -1.317 | 2.007 | 57.465 | 414.144 | 246.439 | 55.281 | 6.932 | 71.836 | 284.43 | 36.059 |
| Operating Expenses
| 943.081 | 1,148.1 | 2,166.549 | 1,657.478 | 2,139.547 | 3,234.362 | 3,199.846 | 3,290.889 | 3,247.802 | 2,732.43 | 4,803.63 | 4,391.163 | 5,039.81 | 5,138.073 | 4,938.955 | 3,300.406 | 2,358.261 | 2,153.174 | 1,998.212 | 1,544.878 |
| Operating Income
| -1,120.799 | -1,106.415 | -2,052.637 | -1,637.936 | -2,189.664 | -2,953.776 | -2,988.595 | -3,004.222 | -2,980.899 | -1,962.474 | -3,785.861 | -1,113.753 | 1,184.137 | 223.323 | 318.672 | 27.169 | -385.426 | -1,348.683 | -833.448 | 35.121 |
| Operating Income Ratio
| -1.837 | -0.975 | -1.779 | -4.926 | -6.925 | -10.527 | -14.147 | -10.48 | -11.168 | -2.549 | -3.72 | -0.34 | 0.19 | 0.042 | 0.061 | 0.008 | -0.195 | -1.676 | -0.716 | 0.022 |
| Total Other Income Expenses Net
| -164.914 | -9 | -517 | 78 | -48 | -238 | 69.333 | 6.651 | 191.453 | 600.556 | 70.13 | -15.672 | 91.135 | 393.668 | 255.637 | 56.462 | 157.131 | 21.23 | 288.846 | 7.601 |
| Income Before Tax
| -1,285.713 | -1,116.42 | -2,570.306 | -1,560.012 | -2,236.997 | -3,194.655 | -2,919.262 | -2,997.571 | -2,789.446 | -1,361.918 | -3,715.731 | -1,129.424 | 1,275.272 | 616.992 | 574.31 | 83.631 | -228.295 | -1,327.453 | -544.602 | 42.723 |
| Income Before Tax Ratio
| -2.107 | -0.984 | -2.228 | -4.692 | -7.074 | -11.386 | -13.819 | -10.457 | -10.451 | -1.769 | -3.651 | -0.345 | 0.205 | 0.115 | 0.109 | 0.025 | -0.116 | -1.65 | -0.468 | 0.027 |
| Income Tax Expense
| 2.425 | 2.223 | 1.234 | 1.623 | 1.56 | -2.841 | 6.905 | 4.492 | -0.626 | -43.791 | -95.187 | -0.671 | 489.337 | 100.097 | 4.414 | 2.224 | 4.066 | -4.09 | -18.903 | 25.33 |
| Net Income
| -1,288.138 | -1,118.644 | -2,571.541 | -1,561.636 | -2,238.558 | -2,934.96 | -2,851.092 | -3,002.063 | -2,788.819 | -1,334.89 | -3,676.647 | -1,103.203 | 726.961 | 566.758 | 510.159 | 148.249 | -202.073 | -1,323.362 | -525.7 | 17.392 |
| Net Income Ratio
| -2.111 | -0.986 | -2.229 | -4.697 | -7.079 | -10.46 | -13.496 | -10.472 | -10.449 | -1.734 | -3.612 | -0.337 | 0.117 | 0.106 | 0.097 | 0.045 | -0.102 | -1.645 | -0.451 | 0.011 |
| EPS
| -6.05 | -5.81 | -13.72 | -8.86 | -13.73 | -19.9 | -19.39 | -20.42 | -18.97 | -9.09 | -28.2 | -10.23 | 6.95 | 5.49 | 5.04 | 1.48 | -2.05 | -13.53 | -5.44 | 0.18 |
| EPS Diluted
| -6.05 | -5.81 | -13.72 | -8.86 | -13.73 | -19.9 | -19.39 | -20.42 | -18.97 | -9.09 | -28.2 | -10.23 | 6.2 | 4.8 | 4.34 | 1.27 | -2.05 | -13.53 | -5.44 | 0.15 |
| EBITDA
| -1,136.156 | -1,123.093 | -1,537.574 | -1,668.178 | -2,110.114 | -2,326.154 | -2,897.852 | -2,925.662 | -3,028.545 | -2,434.087 | -3,738.107 | -1,098.325 | 1,307.957 | 403.828 | 452.138 | 183.036 | -356.868 | -1,164.409 | -722.383 | 121.137 |
| EBITDA Ratio
| -1.862 | -0.99 | -1.333 | -5.017 | -6.673 | -8.29 | -13.718 | -10.206 | -11.347 | -3.161 | -3.673 | -0.335 | 0.21 | 0.075 | 0.086 | 0.055 | -0.181 | -1.447 | -0.62 | 0.077 |